Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $21.5 million.

  • Ultralife's Treasury Shares changed 0.0% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $21.5 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Ultralife's Treasury Shares stood at $4.4 million, which was down 0.0% from $4.4 million recorded in Q2 2025.
  • Over the past 5 years, Ultralife's Treasury Shares peaked at $4.4 million during Q4 2023, and registered a low of $4.4 million during Q1 2021.
  • Moreover, its 4-year median value for Treasury Shares was $4.4 million (2023), whereas its average is $4.4 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 104.96% in 2021, then changed by 0.0% in 2024.
  • Over the past 4 years, Ultralife's Treasury Shares (Quarter) stood at $21.5 million in 2021, then grew by 0.11% to $21.5 million in 2023, then changed by 0.0% to $21.5 million in 2024, then changed by 0.0% to $21.5 million in 2025.
  • Its last three reported values are $21.5 million in Q3 2025, $21.5 million for Q2 2025, and $21.5 million during Q1 2025.